By Caroline Valetkevitch
NEW YORK (Reuters) - U.S. stocks rose on Tuesday, adding to recent gains, after deal news including a bid from FedEx for a Dutch peer suggested companies still see value in the market.
Healthcare stocks led the advance on the S&P 500 with biotech shares up after four days of losses. The Nasdaq Biotech index <.NBI> added 1.8 percent, while the S&P 500 healthcare sector <.SPXHC> gained 0.8 percent.
Shares of FedEx
Two years ago, competition regulators blocked United Parcel Service's
Deals are "the rational outcome of this environment" of low interest rates, said Kim Forrest, senior equity research analyst at Fort Pitt Capital Group in Pittsburgh.
"When you have money in the bank and you either have to return it to shareholders or do something with it ? the next thing is you buy a competitor. You put that cash to work."
Energy shares also gave the market support, with the sector <.SPNY> up 0.8 percent as crude futures
At 12:55 p.m., the Dow Jones industrial average <.DJI> rose 75.28 points, or 0.42 percent, to 17,956.13, the S&P 500 <.SPX> gained 5.83 points, or 0.28 percent, to 2,086.45 and the Nasdaq Composite <.IXIC> added 23.70 points, or 0.48 percent, to 4,941.02.
General Motors
Shares of Twitter
Informatica Corp
Viacom
Advancing issues outnumbered declining ones on the NYSE by 1,719 to 1,251; on the Nasdaq, 1,662 issues rose and 1,002 fell.
The benchmark S&P 500 index was posting 9 new 52-week highs and no new lows; the Nasdaq Composite was recording 58 new highs and 16 new lows.
(Additional reporting by Rodrigo Campos; Editing by Meredith Mazzilli)